Novavax
NVAX
#5744
Rank
ยฃ0.94 B
Marketcap
ยฃ5.71
Share price
-3.24%
Change (1 day)
17.85%
Change (1 year)

P/S ratio for Novavax (NVAX)

P/S ratio as of November 2026 (TTM): 3.04

According to Novavax's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is -6.60. At the end of 2026 the company had a P/S ratio of 3.53.

P/S ratio history for Novavax from 2001 to 2026

PS ratio at the end of each year

Year P/S ratio Change
20263.53242.18%
20251.03-46.96%
20241.94136.46%
20230.822231.11%
20220.6271-93.35%
20219.44-36.78%
202014.9116.33%
20196.90-66.56%
201820.638.17%
201714.9-32.93%
201622.3-64.37%
201562.535.26%
201446.2-9.57%
201351.1303.3%
201212.728.42%
20119.86-98.75%
2010787-4.14%
2009821567.88%
2008123-22.27%
2007158192.21%
200654.189.67%
200528.597.4%
200414.4-18.25%
200317.7286.66%
20024.57-66.51%
200113.6

P/S ratio for similar companies or competitors

Company P/S ratio P/S ratio differencediff. Country
Novartis
NVS
5.00 64.47%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
2.47-18.68%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
4.37 43.74%๐Ÿ‡ฌ๐Ÿ‡ง UK
GSK plc
GSK
2.16-28.89%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
0.7398-75.67%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
> 1000 450,816.10%๐Ÿ‡บ๐Ÿ‡ธ USA
Agenus
AGEN
2.05-32.55%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
BioCryst Pharmaceuticals
BCRX
1.94-36.15%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
0.4176-86.27%๐Ÿ‡บ๐Ÿ‡ธ USA